rs28538230

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_002485.5(NBN):​c.1317A>G​(p.Ile439Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000191 in 1,613,870 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I439V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0010 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

NBN
NM_002485.5 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:9

Conservation

PhyloP100: 0.0150

Publications

5 publications found
Variant links:
Genes affected
NBN (HGNC:7652): (nibrin) Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
NBN Gene-Disease associations (from GenCC):
  • Nijmegen breakage syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Orphanet, ClinGen
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • idiopathic aplastic anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004268855).
BP6
Variant 8-89955363-T-C is Benign according to our data. Variant chr8-89955363-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 127858.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00103 (157/152274) while in subpopulation AFR AF = 0.00359 (149/41560). AF 95% confidence interval is 0.00312. There are 1 homozygotes in GnomAd4. There are 59 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002485.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBN
NM_002485.5
MANE Select
c.1317A>Gp.Ile439Met
missense
Exon 10 of 16NP_002476.2
NBN
NM_001024688.3
c.1071A>Gp.Ile357Met
missense
Exon 11 of 17NP_001019859.1A0A0C4DG07
NBN
NM_001440379.1
c.1071A>Gp.Ile357Met
missense
Exon 10 of 16NP_001427308.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBN
ENST00000265433.8
TSL:1 MANE Select
c.1317A>Gp.Ile439Met
missense
Exon 10 of 16ENSP00000265433.4O60934
NBN
ENST00000697309.1
c.1317A>Gp.Ile439Met
missense
Exon 10 of 15ENSP00000513244.1A0A8V8TKY5
NBN
ENST00000697293.1
c.1317A>Gp.Ile439Met
missense
Exon 10 of 17ENSP00000513230.1A0A8V8TM80

Frequencies

GnomAD3 genomes
AF:
0.00103
AC:
156
AN:
152156
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00357
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000271
AC:
68
AN:
251276
AF XY:
0.000133
show subpopulations
Gnomad AFR exome
AF:
0.00412
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000103
AC:
151
AN:
1461596
Hom.:
0
Cov.:
32
AF XY:
0.0000811
AC XY:
59
AN XY:
727108
show subpopulations
African (AFR)
AF:
0.00406
AC:
136
AN:
33466
American (AMR)
AF:
0.000112
AC:
5
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53400
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111806
Other (OTH)
AF:
0.000149
AC:
9
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00103
AC:
157
AN:
152274
Hom.:
1
Cov.:
32
AF XY:
0.000792
AC XY:
59
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00359
AC:
149
AN:
41560
American (AMR)
AF:
0.000392
AC:
6
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67996
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000414
Hom.:
0
Bravo
AF:
0.00114
ESP6500AA
AF:
0.00567
AC:
25
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000387
AC:
47

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
Microcephaly, normal intelligence and immunodeficiency (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not provided (2)
-
-
2
not specified (2)
-
1
-
Aplastic anemia (1)
-
1
-
Malignant tumor of breast (1)
-
-
1
NBN-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
13
DANN
Benign
0.30
DEOGEN2
Benign
0.068
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.028
N
LIST_S2
Benign
0.63
T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.0043
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L
PhyloP100
0.015
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.15
N
REVEL
Benign
0.010
Sift
Benign
0.098
T
Sift4G
Benign
0.16
T
Polyphen
0.0010
B
Vest4
0.073
MVP
0.42
MPC
0.069
ClinPred
0.0030
T
GERP RS
-1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.034
gMVP
0.11
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28538230; hg19: chr8-90967591; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.